ArticleJAMA network open2025

Prescribing Trends of Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes or Obesity.

Piaopiao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.